The REDEFAR community was created at a meeting held on 8 March 2017 in the CIB-CSIC. It arose from the need to integrate all public and private bodies involved in drug discovery in Spain. The mission of the REDEFAR community is to act as an instrument for creating a coordinated structure for the different stages of early drug discovery in Spain, with the aim of adding value to each of these stages and reducing the risk inherent in the application of transformational science.
The REDEFAR drug discovery community (more than 200 members) combines the expertise of many public-private companies In Spain. The community also act in coordination with the PTEMI, the working group for drug discovery of ASEBIO, the SDDN and other related networks in both Spain and Europe.
If you would like to form part of the REDEFAR community and participate in our activities, please contact us at info@redefar.com
Surge de la necesidad de integrar a todos los actores públicos y privados del entorno de descubrimiento de fármacos español entorno a REDEFAR. La comunidad REDEFAR tiene la misión de ser un instrumento para crear en España una estructura coordinada en las diferentes etapas del descubrimiento temprano de fármacos, buscando añadir valor en cada una de ellas y reducir el riesgo intrínseco a este tipo de actividades de aplicación de ciencia transformacional.
